XT
MIST icon

XTX Topco’s Milestone Pharmaceuticals MIST Stock Holding History

XTX Topco’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.3K Sell
26,317
-94,285
-78% -$151K ﹤0.01% 3790
2026
Q1 		$144K Sell
120,602
-51,358
-30% -$89.9K ﹤0.01% 2978
2025
Q4 		$347K Sell
171,960
-15,341
-8% -$33K 0.01% 1942
2025
Q3 		$375K Buy
187,301
+26,338
+16% +$46.3K 0.02% 1319
2025
Q2 		$312K Buy
160,963
+108,959
+210% +$145K 0.01% 1401
2025
Q1 		$41.6K Buy
52,004
+17,950
+53% +$35.7K ﹤0.01% 2022
2024
Q4 		$80.4K Buy
+34,054
New +$58.5K 0.01% 1812
2024
Q2 		– Sell
-13,403
Closed -$24K – 2236
2024
Q1 		$24K Buy
+13,403
New +$21.8K ﹤0.01% 1590
2023
Q2 		– Sell
-12,636
Closed -$49.8K – 1658
2023
Q1 		$49.8K Sell
12,636
-56,820
-82% -$208K 0.01% 1168
2022
Q4 		$275K Buy
+69,456
New +$366K 0.06% 643

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

XTX Topco's MIST Position: Q2 2026 in Review

XTX Topco reduced its Milestone Pharmaceuticals (MIST) stake by 78% in Q2 2026, selling an estimated $151K and leaving 26,317 shares worth $35.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3790.

XTX Topco first reported a position in MIST in Q4 2022 and has held it in 10 quarters since. The position peaked at $375K in Q3 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • XTX Topco held 26,317 shares of Milestone Pharmaceuticals worth $35.3K as of Q2 2026.
  • XTX Topco sold 94,285 Milestone Pharmaceuticals shares in Q2 2026, an estimated $151K.
  • Milestone Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3790 holding.
  • XTX Topco first reported a position in Milestone Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
  • XTX Topco's Milestone Pharmaceuticals position peaked at $375K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.